Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Torrent Pharmaceuticals Ltd banner
T

Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM

Watchlist Manager
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Watchlist
Price: 4 978.2998 INR -1.72% Market Closed
Market Cap: ₹1.7T
Write Note Create Alert Ask AI

Wall St Price Targets

TORNTPHARM Price Targets Summary
Torrent Pharmaceuticals Ltd

Wall Street analysts forecast TORNTPHARM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TORNTPHARM is 4 906.2 INR with a low forecast of 3 807.7 INR and a high forecast of 5 694.15 INR.

TORNTPHARM Lowest Forecast
Wall Street Target
₹3 807.7
-24% Downside
TORNTPHARM Average Forecast
Wall Street Target
₹4 906.2
-1% Downside
TORNTPHARM Highest Forecast
Wall Street Target
₹5 694.15
14% Upside
Lowest Forecast
Price Target
3 807.7 INR
24% Downside
Average Forecast
Price Target
4 906.2 INR
1% Downside
Highest Forecast
Price Target
5 694.15 INR
14% Upside
Torrent Pharmaceuticals Ltd Competitors:
Price Targets
E
6657
Energenesis Biomedical Co Ltd
22% Upside
3
UUU
3U Holding AG
75% Upside
E
6657
Energenesis Biomedical Co Ltd
22% Upside
3
UUU
3U Holding AG
75% Upside

Revenue
Forecast

12% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
12% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 20%.

What are analyst estimates?

Gross Profit
Forecast

14% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat
14% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat

Over the last 14 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is 19%.

What are analyst estimates?

Operating Income
Forecast

16% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
16% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 22%.

What are analyst estimates?

Pre-Tax Income
Forecast

16% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
16% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 2 years is 30%.

What are analyst estimates?

Net Income
Forecast

16% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
16% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 3 years is 24%.

What are analyst estimates?

Continue TORNTPHARM Research

Summary
TORNTPHARM intrinsic value, competitors valuation, and company profile.
DCF Valuation
TORNTPHARM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TORNTPHARM stock valuation using valuation multiples.
Wall St Estimates
TORNTPHARM price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TORNTPHARM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Torrent Pharmaceuticals Ltd listings:
BSE • INR
500420
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TORNTPHARM's stock price target?
Price Target
4 906.2 INR

According to Wall Street analysts, the average 1-year price target for TORNTPHARM is 4 906.2 INR with a low forecast of 3 807.7 INR and a high forecast of 5 694.15 INR.

What is the Revenue forecast for Torrent Pharmaceuticals Ltd?
Projected CAGR
20%

Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 20%.

What is the Gross Profit forecast for Torrent Pharmaceuticals Ltd?
Projected CAGR
19%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 3 years is 19%.

What is the Operating Income forecast for Torrent Pharmaceuticals Ltd?
Projected CAGR
22%

Over the last 14 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 22%.

What is the Pre-Tax Income forecast for Torrent Pharmaceuticals Ltd?
Projected CAGR
30%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 2 years is 30%.

What is the Net Income forecast for Torrent Pharmaceuticals Ltd?
Projected CAGR
24%

Over the last 14 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 3 years is 24%.

Back to Top
ALPHA SPREAD
Follow us
Join 349,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett